Research Areas

Focusing on the cutting-edge fields of "Integrated Bone-Muscle Therapy" and "Anti-Bone Aging," this approach integrates biomaterials, regenerative factors, and stem cell technologies. The strategy aims to develop comprehensive solutions covering osteoporosis and fracture prevention, bone defect repair, cartilage regeneration, and arthritis treatment, while synergistically promoting muscle health. Continuous advancement in formulation innovation and delivery system upgrades is enabling a transition from pre-filled subcutaneous injections to advanced options including painless microneedle patches and stem cell-based gels. This evolution significantly enhances treatment accessibility and patient compliance, establishing a leading regenerative medicine pathway for these conditions.

Focusing on "skin and tissue" regeneration, this field utilizes advanced biotechnology to achieve functional repair and structural reconstruction. Core technology centers on key growth factors including EGF and bFGF combined with advanced hydrogel delivery systems, precisely regulating cell proliferation, angiogenesis and tissue remodeling to effectively promote wound healing and skin regeneration. Products address clinical scenarios including burns, refractory wounds (e.g., diabetic foot), plastic surgery and post-laser rehabilitation, driving treatment strategies from passive coverage to active regeneration. The deep integration of clinical needs with regenerative medicine frontiers combines significant technological differentiation with substantial societal value.

Advancing the frontiers of "ocular regeneration" to achieve functional restoration of the cornea, retina, and ocular surface, addressing severe conditions such as corneal injury, dry eye disease, and age-related macular degeneration (AMD). For corneal repair and dry eye treatment, bioactive proteins such as hEGF are applied to promote epithelial regeneration and tear film stabilization. In AMD therapeutics, efforts prioritize anti-VEGF biologics and gene-based strategies to suppress pathological angiogenesis and preserve photoreceptor cells. These initiatives aim to achieve precise and efficient regeneration from the ocular surface to the fundus, delivering innovative solutions for patients worldwide.

Research advances in "ENT regenerative medicine" center on restoring auditory, olfactory, and mucosal functions. In auditory regeneration, development focuses on brain-derived neurotrophic factor-based therapies to promote hair cell survival and neuronal repair, potentially reversing certain types of sensorineural hearing loss. Related formulations have entered Phase II clinical trials. For nasal and laryngeal applications, efforts target mucosal tissue reconstruction and olfactory function recovery, addressing classical therapeutic challenges in ENT disorders and providing novel regenerative solutions for patients globally.